A double blind, randomized, placebo-controlled phase II study to assess the safety and efficacy of orally administered SP-303 for the symptomatic treatment of diarrhea in patients with AIDS.
Holodniy M; Koch J; Mistal M; Schmidt JM; Khandwala A; Pennington JE; Porter SB; The American Journal Of Gastroenterology, 1999, vol. 94, issue 11, p 3267, ISSN 00029270. ISBN 00029270.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef